CompletedPhase 4NCT00391105
Remifentanil Versus Morphine for Sedation of Premature Neonates With Respiratory Distress Syndrome
Studying Neonatal acute respiratory distress syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Federal University of Minas Gerais
- Principal Investigator
- Yerkes P Silva, MD, MScFaculty of Medicine from Federal University of Minas Gerais
- Intervention
- Remifentanil(drug)
- Eligibility
- All sexes
- Timeline
- 2004 – 2005
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00391105 on ClinicalTrials.govOther trials for Neonatal acute respiratory distress syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07437391Effect of L-Carnitine Supplementation in Preterm NeonatesMuhammad Aamir Latif
- RECRUITINGNCT07154134Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress SyndromeTanta University
- RECRUITINGNCT06874478Respiratory Distress and Elective Cesarean Section at TermAssiut University
- RECRUITINGPHASE4NCT06074380Non Inferiority Trial Investigating Surfactants Administered Via MISTEndeavor Health
- RECRUITINGNCT06031324The Role of Lung Ultrasonography Score in Predicting Prognosis in Term and Late Preterm Newborns With Postnatal Respiratory DistressBursa City Hospital
See all trials for Neonatal acute respiratory distress syndrome →